Clinical studies of dopaminergic mechanisms.
D000978:Antiparkinson Agents / Q000494:pharmacology*; D004149:Dioxoles / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D004341:Drug Evaluation; D006220:Haloperidol / Q000494:pharmacology*; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000378:metabolism; D010880:Piperidines / Q000494:pharmacology*; D011339:Probenecid / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology
D000978:Antiparkinson Agents; D004149:Dioxoles; D010880:Piperidines; D011743:Pyrimidines; D007980:Levodopa; D006220:Haloperidol; D011339:Probenecid; D004298:Dopamine; D006719:Homovanillic Acid